StarTric
6 employees on LinkedIn · 2 known investors
StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.
Founders & leadership
MD
Michele De BonisFounder
OA
Ottavio AlfieriFounder
Investors · 2
Frequently asked questions
- What does StarTric do?
- StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.
- Who founded StarTric?
- StarTric was founded by Michele De Bonis, Ottavio Alfieri.
- Who are StarTric's investors?
- StarTric's investors include Growth Capital, NLC.